Ami Lifesciences appoints Amit Kaptain as CEO
Sun Pharmaceutical Industries Ltd on Wednesday said it along with its US-based arm Ranbaxy, Inc, has signed a USD 485 million settlement with two plaintiff groups regarding Ranbaxy generic drug application antitrust litigation.
When Sun Pharma acquired troubled Ranbaxy in 2014 for $4 billion, the India generics giant knew it was inheriting some major compliance problems. At the time, four of Ranbaxy’s five plants were sidelined by the FDA.
Esomeprazole 40mg iv powder for solution is expected to face supply disruption following limited supply and increased demand.
Pfizer, Ranbaxy Sued Over Delay Of Generic Lipitor
US pharmaceutical spending during the year 2020, is expected to top $400 billion. Americans spend about $1,200 on prescription drugs per year, the highest in the developed world. Generics are a critical cost reduction component of pharma spending; saving a whopping $2 trillion in the past ten years. 90% of the prescriptions are dispensed with generics, yet they account for only 26% of the drug spending. Without generic drugs, most private and public health programs would be cost-prohibitive.
GlaxoSmithKline has offloaded a chunk of its consumer health business in a deal that earned the company more proceeds than expected.
Enforcement Report - Week of March 25, 2020
Health Canada Issues Recall of Sun Pharma Canada`s Ranbaxy Metformin Product Recall
Certain brands of diabetes drugs containing metformin.